Company Description
Organigram Global Inc. engages in the production and sale of cannabis and cannabis-derived products in Canada.
It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, beverages, gummies, and concentrates; and adult use recreational cannabis under the SHRED, Big Bag O’ Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co., Boxhot, Edison JOLTS, Wola, Rizzlers, DEBUNK, Tremblant, and Laurentian brands.
The company also engages in the wholesale shipping of cannabis plant cuttings and dried flowers to other licensed producers.
It sells cannabis products to wholesale and retail channels in the recreational and medical cannabis regimes, as well as through online.
Organigram Global Inc. was formerly known as Organigram Holdings Inc. and changed its name to Organigram Global Inc. in March 2025.
The company is headquartered in Toronto, Canada.
| Country | Canada |
| Founded | 2013 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 898 |
| CEO | Beena Goldenberg |
Contact Details
Address: 145 King Street West, Suite #1400 Toronto, ON M5H 1J8 Canada | |
| Phone | 844 644 4726 |
| Website | organigram.ca |
Stock Details
| Ticker Symbol | OGI |
| Exchange | NASDAQ |
| Fiscal Year | October - September |
| Reporting Currency | CAD |
| CIK Code | 1620737 |
| CUSIP Number | 68617J100 |
| ISIN Number | CA68617J1003 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Greg Guyatt C.A., CPA | Chief Financial Officer |
| Helen Martin | Chief Legal Officer and Corporate Secretary |
| Timothy Emberg | President of Organigram Canada |
| Paolo De Luca C.A., C.F.A | Chief Strategy Officer |
| Max Schwartz | Director of Investor Relations |
| Bradley Gunter | Senior Vice President of Sales |
| Katrina May McFadden | Chief People Officer |
| Gregory Engel | Special Advisor |
| Megan Amber McCrae | Senior Vice President of Corporate Strategy and International Growth |
| Borna Zlamalik | Senior Vice President of Research & Development and Innovation |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Dec 16, 2025 | 40-F | Filing |
| Dec 5, 2025 | 6-K | Report of foreign issuer |
| Dec 4, 2025 | 6-K | Report of foreign issuer |
| Nov 25, 2025 | 6-K | Report of foreign issuer |
| Oct 29, 2025 | 6-K | Report of foreign issuer |
| Oct 21, 2025 | 6-K | Report of foreign issuer |
| Oct 9, 2025 | 6-K | Report of foreign issuer |
| Sep 2, 2025 | 6-K | Report of foreign issuer |
| Aug 13, 2025 | 6-K | Report of foreign issuer |
| Aug 1, 2025 | 6-K | Report of foreign issuer |